Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-01 for dry eye post-PRK
NCT05045508Phase 3Unknown
- Start
- Aug 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in dry eye disease (DED). Status: unknown.
02
Drugs
varenicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05045508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045508.